Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fonseca

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 11, 2008
Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitusV Fonseca, M Baron, Q Shao, et al.
American Journal of Clinical Pathology|December 1, 1996
Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular diseaseS C Guba, L M Fink, V Fonseca
The American Journal of the Medical Sciences|April 16, 1998
Hyperhomocysteinemia and premature vascular occlusive diseaseS C Guba, L M Fink, V Fonseca
Endocrine Reviews|October 26, 1999
Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosisV Fonseca, S C Guba, L M Fink
Diabetes, Obesity & Metabolism|December 24, 2011
Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosageV Fonseca, T Zhu, C Karyekar, et al.
East African Medical Journal|January 1, 1985
Non-ketotic diabetes mellitus in young non-obese Saudi ArabiansV Fonseca, M A Laajam, R K Tongia
Journal of Pharmaceutical and Biomedical Analysis|February 15, 2005
Assays of physical stability and antioxidant activity of a topical formulation added with different plant extractsValéria M Di Mambro, Maria J V Fonseca
JAMA|February 7, 2001
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trialV Fonseca, J Rosenstock, R Patwardhan, et al.
Diabetes, Obesity & Metabolism|April 13, 2011
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemiaV Fonseca, J Gill, R Zhou, et al.
Endocrine Reviews|February 11, 2004
Nontraditional risk factors for cardiovascular disease in diabetesV Fonseca, C Desouza, S Asnani, et al.
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 11, 2008
Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitusV Fonseca, M Baron, Q Shao, et al.
American Journal of Clinical Pathology|December 1, 1996
Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular diseaseS C Guba, L M Fink, V Fonseca
The American Journal of the Medical Sciences|April 16, 1998
Hyperhomocysteinemia and premature vascular occlusive diseaseS C Guba, L M Fink, V Fonseca
Endocrine Reviews|October 26, 1999
Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosisV Fonseca, S C Guba, L M Fink
Diabetes, Obesity & Metabolism|December 24, 2011
Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosageV Fonseca, T Zhu, C Karyekar, et al.
East African Medical Journal|January 1, 1985
Non-ketotic diabetes mellitus in young non-obese Saudi ArabiansV Fonseca, M A Laajam, R K Tongia
Journal of Pharmaceutical and Biomedical Analysis|February 15, 2005
Assays of physical stability and antioxidant activity of a topical formulation added with different plant extractsValéria M Di Mambro, Maria J V Fonseca
JAMA|February 7, 2001
Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trialV Fonseca, J Rosenstock, R Patwardhan, et al.
Diabetes, Obesity & Metabolism|April 13, 2011
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemiaV Fonseca, J Gill, R Zhou, et al.
Endocrine Reviews|February 11, 2004
Nontraditional risk factors for cardiovascular disease in diabetesV Fonseca, C Desouza, S Asnani, et al.
Pageof 22